Related references
Note: Only part of the references are listed.Update on the use of immunoglobulin in human disease: A review of evidence
Elena E. Perez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
A comprehensive review of the neonatal Fc receptor and its application in drug delivery
Joao Pedro Martins et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin
Rolf Bambauer et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions
Algirdas Grevys et al.
JOURNAL OF IMMUNOLOGY (2015)
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity
Yasmina Noubia Abdiche et al.
MABS (2015)
Fully human monoclonal antibocy inibitors of the neonatal Fc receptor reduce circulating IgG in non-human primates
Andrew E. Nixon et al.
FRONTIERS IN IMMUNOLOGY (2015)
pH-dependent Binding Engineering Reveals an FcRn Affinity Threshold That Governs IgG Recycling
M. Jack Borrok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Characterization and screening of IgG binding to the neonatal Fc receptor
Tobias Neuber et al.
MABS (2014)
Neonatal Fc Receptor Expression in Dendritic Cells Mediates Protective Immunity against Colorectal Cancer
Kristi Baker et al.
IMMUNITY (2013)
Using multifocal plane microscopy to reveal novel trafficking processes in the recycling pathway
Zhuo Gan et al.
JOURNAL OF CELL SCIENCE (2013)
Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules
Andrew W. Weflen et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis
Dilip K. Challa et al.
MABS (2013)
Adverse Effects of Human Immunoglobulin Therapy
E. Richard Stiehm
TRANSFUSION MEDICINE REVIEWS (2013)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
Dipesh A. Patel et al.
JOURNAL OF IMMUNOLOGY (2011)
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
Alina Sesarman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Nathanael L. Dirks et al.
CLINICAL PHARMACOKINETICS (2010)
A Software Framework for the Analysis of Complex Microscopy Image Data
Jerry Chao et al.
IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE (2010)
Comparing the Autoantibody Levels and Clinical Efficacy of Double Filtration Plasmapheresis, Immunoadsorption, and Intravenous Immunoglobulin for the Treatment of Late-onset Myasthenia Gravis
Jun-Feng Liu et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2010)
Inhibitors of the FcRn:IgG Protein-Protein Interaction
Susan C. Low et al.
AAPS JOURNAL (2009)
Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Saiju Jacob et al.
CURRENT NEUROPHARMACOLOGY (2009)
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
Glinda S. Cooper et al.
JOURNAL OF AUTOIMMUNITY (2009)
Serum Immunoglobulins and Risk of Infection: How Low Can You Go?
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
Carlos Vaccaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β2-microglobulin gene
MA Wani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
From sorting endosomes to exocytosis: Association of Rab4 and Rab11 GTPases with the fc receptor, FcRn, during recycling
ES Ward et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Conferring the binding properties of the mouse MHC class I-related receptor, FcRn, onto the human ortholog by sequential rounds of site-directed mutagenesis
JC Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn
RJ Ober et al.
JOURNAL OF IMMUNOLOGY (2004)
Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level
RJ Ober et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protein A immunoadsorption:: a novel and effective adjuvant treatment of severe pemphigus
E Schmidt et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs
DC Roopenian et al.
JOURNAL OF IMMUNOLOGY (2003)
Analysis of exponential data using a noniterative technique: application to surface plasmon experiments
RJ Ober et al.
ANALYTICAL BIOCHEMISTRY (2003)
Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
WF Dall'Acqua et al.
JOURNAL OF IMMUNOLOGY (2002)
The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans
M Firan et al.
INTERNATIONAL IMMUNOLOGY (2001)
Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor
AP West et al.
BIOCHEMISTRY (2000)
Share Paper
